Coutts, Shelagh B
$100,000.00 CAD
≈ 16 months of average Canadian pay
- Department
- Canadian Institutes of Health Research
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2016-2017
- Agreement period
- July 1, 2016 – June 30, 2017
- Reference
- cihr-irsc:236-2016-2017-Q2-00652
Published purpose
TEMPO-2 - Multicentre, prospective randomized open label, blinded-endpoint (PROBE) controlled trial of thrombolysis with low dose Tenecteplase (TNK-tPA) versus standard of care in the prevention of disability at 3 months in minor ischemic stroke with proven acute symptomatic occlusion.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions